Peter Gruber

USPTO Granted Patents = 13 (Patent Applications = 5)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 1)

Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 180(Granted Patents)

Location History:

Bottmingen, CH (1999 - 2001)
Freiburg, DE (2004 - 2005)
Merzhausen, DE (2011 - 2020)

Company Filing History:

Disphar International Bv

patents

4. 1 out of 1

Apogepha Arzneimittel Gmbh

patent

Years Active: 1999-2020

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10603280 - Active ingredient containing stabilised solid medicinal forms and methods for the production thereof (2020-03-31),

2. 10206879 - Active ingredient containing stabilised solid forms and method for the production thereof (2019-02-19),

3. 9775807 - Stabilized solid medicinal forms containing active ingredient and method for the production thereof (2017-10-03),

4. 9205054 - Solubilized ibuprofen (2015-12-08),

5. 8956647 - Pellet formulation for the treatment of the intestinal tract (2015-02-17),

6. 8940328 - Pellet formulation for the treatment of the intestinal tract (2015-01-27),

7. 8911778 - Pellet formulation for the treatment of the intestinal tract (2014-12-16),

8. 8889184 - Particulate form of a pharmaceutical composition which is easy to swallow (2014-11-18),

9. 7943176 - Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient (2011-05-17),

10. 6962717 - Pharmaceutical compositions (2005-11-08),

11. 6709678 - Easy to swallow oral medicament composition (2004-03-23),

12. 6171617 - Effervescent ibuprofen preparation and process for the production thereof (2001-01-09),

13. 5932249 - Budesonide pellets with a controlled released pattern and process for (1999-08-03),

Title: The Innovative Contributions of Peter Gruber

Introduction

Peter Gruber is a notable inventor based in Merzhausen, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work primarily focuses on the development of solid medicinal forms that enhance the stability and efficacy of active ingredients.

Latest Patents

Among his latest patents, Gruber has developed innovative solid medicinal forms containing at least one active ingredient and a pharmaceutically compatible, water-soluble drying agent. This drying agent is selected from trimagnesium dicitrate and/or calcium chloride. The solid medicinal forms he has created exhibit a drying loss of at most 6% and a relative equilibrium moisture content of 25% or less. Additionally, his inventions include solid medicinal forms that contain moisture-sensitive active ingredients combined with trimagnesium dicitrate.

Career Highlights

Throughout his career, Peter Gruber has worked with prominent companies in the pharmaceutical industry, including Losan Pharma GmbH and Dr. Falk Pharma GmbH. His expertise in developing stable medicinal formulations has made him a valuable asset in these organizations.

Collaborations

Gruber has collaborated with several professionals in his field, including Norbert Otterbeck and Dirk Spickermann. These partnerships have contributed to the advancement of his innovative projects and the successful development of his patents.

Conclusion

Peter Gruber's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his commitment to improving medicinal formulations. His work continues to influence the field and pave the way for future advancements in drug stability and efficacy.

This text is generated by artificial intelligence and may not be accurate.